BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35956315)

  • 21. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
    Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
    Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress in diabetic nephropathy.
    Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
    Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
    Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
    FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction.
    Lassén E; Daehn IS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
    Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
    Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.
    Liu W; Chen X; Wang Y; Chen Y; Chen S; Gong W; Chen T; Sun L; Zheng C; Yin B; Li S; Luo C; Huang Q; Xiao J; Xu Z; Peng F; Long H
    Pharmacol Res; 2019 Dec; 150():104506. PubMed ID: 31669149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
    Thallas-Bonke V; Tan SM; Lindblom RS; Snelson M; Granata C; Jha JC; Sourris KC; Laskowski A; Watson A; Tauc M; Rubera I; Zheng G; Shah AM; Harris DCH; Elbatreek MH; Kantharidis P; Cooper ME; Jandeleit-Dahm K; Coughlan MT
    Nephrol Dial Transplant; 2021 May; 36(6):988-997. PubMed ID: 33367789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.
    Li X; Xu B; Wu J; Pu Y; Wan S; Zeng Y; Wang M; Luo L; Zhang F; Jiang Z; Xu Y
    Oxid Med Cell Longev; 2022; 2022():7177889. PubMed ID: 35498124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.
    Lee HB; Yu MR; Yang Y; Jiang Z; Ha H
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S241-5. PubMed ID: 12874439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY.
    Sun L; Dutta RK; Xie P; Kanwar YS
    J Biol Chem; 2016 Mar; 291(11):5688-5707. PubMed ID: 26792859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms.
    Ye S; Zhang M; Tang SCW; Li B; Chen W
    Mol Biol Rep; 2024 Feb; 51(1):304. PubMed ID: 38361088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy.
    Sheng J; Li H; Dai Q; Lu C; Xu M; Zhang J; Feng J
    Cell Physiol Biochem; 2018; 48(4):1675-1693. PubMed ID: 30077998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.
    Nakamura H; Matoba S; Iwai-Kanai E; Kimata M; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Okigaki M; Adachi S; Tanaka H; Takamatsu T; Matsubara H
    Circ Heart Fail; 2012 Jan; 5(1):106-15. PubMed ID: 22075967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria in Diabetic Kidney Disease.
    Ahmad AA; Draves SO; Rosca M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
    Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
    Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.